Novavax Inc vs Clear Secure Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Clear Secure Inc trades at $57.03 (market cap $5.76B). The key difference: Clear Secure Inc is far larger — about 4.4× Novavax Inc's market cap, and Clear Secure Inc pays a 1.05% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | YOU | |
|---|---|---|
Market Cap | $1.30B | $5.76B |
Sector | Health | Technology |
52-Week High | $11.19 | $62.36 |
52-Week Low | $6.22 | $28.84 |
Enterprise Value | $800.50M | $5.07B |
Dividend Yield | — | 1.05% |
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →